U.S., Jan. 31 -- ClinicalTrials.gov registry received information related to the study (NCT07378709) titled 'Exploratory Blood-Based Biomarkers in TACE-Treated Hepatocellular Carcinoma: A Pilot Study' on Jan. 22.
Brief Summary: The goal of this observational study is to evaluate changes in selected biomarkers and their potential connection with early radiological outcomes in adult patients with hepatocellular carcinoma (HCC) who are candidates for TACE treatment. The main questions it aims to answer are whether specific biomarkers change in response to TACE treatment and if there is a correlation between these changes and early radiological treatment response as measured by mRECIST criteria. Participants will undergo standard-of-care Trans...